Bank of Montreal’s Belite Bio BLTE Stock Holding History

Bank of Montreal’s Portfolio BLTE Stock Details BLTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.55M	Buy	15,981 +443	+3%	+$74.5K	﹤0.01%	1565
2025 Q4	$2.5M	Buy	+15,538	New	+$1.84M	﹤0.01%	1569

Other funds holding BLTE

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's BLTE Position: Q1 2026 in Review

Bank of Montreal increased its Belite Bio (BLTE) stake by 2.9% in Q1 2026, buying an estimated $74.5K and bringing the position to 15,981 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1565.

Bank of Montreal first reported a position in BLTE in Q4 2025 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

Bank of Montreal held 15,981 shares of Belite Bio worth $2.55M as of Q1 2026.
Bank of Montreal bought 443 Belite Bio shares in Q1 2026, an estimated $74.5K.
Belite Bio made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #1565 holding.
Bank of Montreal first reported a position in Belite Bio in Q4 2025 and has held it in 2 quarters since.
75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.